Abstract
Nanopore sequencing, a next-generation sequencing technology, is poised to transform life sciences, forensics, and healthcare. While prior research has explored its technical and biomedical potential, its societal implications remain underexamined. This dialogue bridges this gap by analysing the ethical, legal, and social dimensions of nanopore sequencing through the lenses of Diffusion Theory and Actor-Network Theory. We investigate how various stakeholders, such as scientists, corporations, policymakers, and consumers, shape its development and adoption, highlighting the power dynamics and socio